Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma

A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients

NCT04061278 ·Status: UNKNOWN ·Phase: PHASE3

Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer

NCT05174156 ·Status: UNKNOWN ·Phase: PHASE2

The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma

NCT02116231 ·Status: UNKNOWN ·Phase: PHASE2

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

NCT01817023 ·Status: UNKNOWN ·Phase: PHASE3

Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma

NCT01616849 ·Status: COMPLETED ·Phase: PHASE2

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

NCT02562599 ·Status: COMPLETED ·Phase: PHASE2

PET/MR in Locally Advanced Nasopharyngeal Carcinoma

NCT03657017 ·Status: RECRUITING ·Phase: NA

CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy

NCT03529279 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

NCT06197776 ·Status: RECRUITING

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

NCT06059261 ·Status: RECRUITING ·Phase: PHASE2

Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients

NCT02044562 ·Status: UNKNOWN ·Phase: NA

A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

NCT07062484 ·Status: NOT_YET_RECRUITING ·Phase: NA

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

NCT03389295 ·Status: COMPLETED ·Phase: PHASE2

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

NCT03668366 ·Status: COMPLETED ·Phase: PHASE2

Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma

NCT02089204 ·Status: UNKNOWN

GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma

NCT03723343 ·Status: UNKNOWN

Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study

NCT02187315 ·Status: UNKNOWN ·Phase: PHASE2

Study on Clinical Features, Treatment Mode and Survival of Sarcoma

NCT05453409 ·Status: RECRUITING

Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma

NCT03668730 ·Status: UNKNOWN ·Phase: PHASE2

Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer

NCT02937519 ·Status: UNKNOWN ·Phase: PHASE2

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

NCT07248956 ·Status: RECRUITING ·Phase: PHASE2

Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma

NCT02569788 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Immune Score Based Radiomics in Nasopharyngeal Carcinoma

NCT05126160 ·Status: RECRUITING

Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.

NCT06529562 ·Status: RECRUITING ·Phase: NA

The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma

NCT04769076 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2